 CARLSBAD, Calif., June 07, 2021 GLOBE NEWSWIRE -- Design Therapeutics, Inc. Nasdaq: DSGN, a biotechnology company developing treatments for degenerative genetic disorders, today reported that João Siffert, M.D., president and chief executive officer, will participate in a fireside chat during the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 1:20 p.m. ET. 